These findings suggest applicability of α-MSH analogues for therapeutic use in hypertensive disease states and merit further attention to investigate whether selective and dual targeting of MC1 and MC3 receptors could have beneficial effects in more severe models of hypertension. This evidence concerns the gene ATP7A and hypertensive disorder.